Heron Therapeutics receives Nasdaq notice for bid price below $1.00; 180 days to cure

HERON THERAPEUTICS, INC. /DE/

On June 25, 2026, Nasdaq notified Heron that its common stock closing bid price was below $1.00 for 30 consecutive trading days (May 12–June 24, 2026).
Company has 180 calendar days, until December 22, 2026, to regain compliance by maintaining bid price ≥ $1.00 for at least 10 consecutive days.
If not cured, Heron may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure via reverse stock split.
There is no immediate impact on trading; shares continue to trade under HRTX on Nasdaq Capital Market.
Company intends to monitor share price and explore options to regain compliance.

Featured in Daily 8-K Digest

Selected #2 for 2026-06-25. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.